BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37030151)

  • 1. Efficacy of Newcastle disease LaSota vaccine-induced hemagglutination inhibition antibodies against challenges with heterologous virulent strains of genotypes VII and IX.
    Liu M; Shen X; Li J; Yu Y; Fan J; Jia X; Dai Y
    Vet Immunol Immunopathol; 2023 May; 259():110591. PubMed ID: 37030151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Different Levels of Maternally Derived Genotype VII Newcastle Disease Virus-Specific Hemagglutination Inhibition Antibodies on Protection against Virulent Challenge in Chicks.
    Liu M; Shen X; Yu Y; Li J; Fan J; Jia X; Dai Y
    Viruses; 2023 Aug; 15(9):. PubMed ID: 37766246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
    Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
    Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
    Wajid A; Basharat A; Bibi T; Rehmani SF
    Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
    Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
    Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
    Xiao S; Nayak B; Samuel A; Paldurai A; Kanabagattebasavarajappa M; Prajitno TY; Bharoto EE; Collins PL; Samal SK
    PLoS One; 2012; 7(12):e52751. PubMed ID: 23285174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
    Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
    Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the HN Antigenic Difference between the Vaccine Strain and the Challenge Strain of Newcastle Disease Virus on Virus Shedding and Transmission.
    Liu J; Zhu J; Xu H; Li J; Hu Z; Hu S; And XW; Liu X
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28809802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
    Liu H; de Almeida RS; Gil P; Majó N; Nofrarías M; Briand FX; Jestin V; Albina E
    Vaccine; 2018 Jun; 36(27):3917-3925. PubMed ID: 29843999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of the Newcastle disease virus genotype VII-matched vaccine in commercial layers.
    Sultan HA; Talaat S; Elfeil WK; Selim K; Kutkat MA; Amer SA; Choi KS
    Poult Sci; 2020 Mar; 99(3):1275-1286. PubMed ID: 32111305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance comparison of homologous and heterologous Newcastle disease virus in vaccines and antibody tests.
    Pandarangga P; McAllister MM; Peaston AE; Ngai YT; Cahyono MI; Hemmatzadeh F
    Res Vet Sci; 2022 Dec; 149():82-89. PubMed ID: 35777283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    Manoharan VK; Varghese BP; Paldurai A; Samal SK
    PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
    Cornax I; Miller PJ; Afonso CL
    Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of genotype-matched Newcastle disease virus vaccine formulated in carboxymethyl sago starch acid hydrogel in chickens vaccinated via different routes.
    Mahamud SNA; Bello MB; Ideris A; Omar AR
    J Vet Sci; 2022 Jul; 23(4):e25. PubMed ID: 35920119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genotype VII Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding.
    Xu X; Ding Z; Yuan Q; Ding J; Li J; Wang W; Cong Y; Ouyang W; Wang Y; Qian J; Yin R
    Vaccine; 2019 Jan; 37(3):444-451. PubMed ID: 30545716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel genotype VII Newcastle disease virus vaccine candidate generated by mutation in the L and F genes confers improved protection in chickens.
    Ji Y; Liu T; Du Y; Cui X; Yu Q; Wang Z; Zhang J; Li Y; Zhu Q
    Vet Microbiol; 2018 Mar; 216():99-106. PubMed ID: 29519533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus.
    Hossain I; Subarna JF; Kabiraj CK; Begum JA; Parvin R; Martins M; Diel DG; Chowdhury EH; Islam MR; Nooruzzaman M
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.